Skip links

Uptake Strategies responds to growth with pivotal board level changes

New roles for Stephanie and Maxine, and a brand new addition to the Uptake Team.

Here at Uptake Strategies, we have made key changes to our senior leadership team, as we continue to deliver our vision to be a global force for growth for its people and clients.

Our founder, Stephanie Hall has led Uptake Strategies as Managing Director for 17 years, during which time she has been joined by fellow board members Maxine Smith, Chelsea Foxwell, Melissa Dagless, Kelly McDonald, and Simon Hall. Following sustained success and rapidly increasing demand, Stephanie has now taken on the role of Chief Executive Officer.

Maxine Smith, who started working with Uptake Strategies in 2009 and has since been instrumental in her leadership of key client accounts, now moves into the Managing Director role, taking on responsibility for running the business, together with key client and team responsibilities.

Further strengthening the team, Michael Oliver joins our board as Head of Practice. Michael brings with him huge industry experience across multiple therapy areas, having launched several medicines across many geographies. He has most recently held roles as UK & Ireland General Manager for Vertex and Sobi.

Speaking about these new strategic decisions, Stephanie Hall, CEO, Uptake Strategies said: “We are on a mission to inspire exceptional performance across our industry, while remaining true to our values. I am incredibly proud of the depth of skill and expertise represented on our board; Maxine’s transformational approach to the Managing Director role, paired with the addition of Michael’s significant experience marks the beginning of an exciting new chapter for our business.”